Utpal Koppikar - 09 Jul 2021 Form 4 Insider Report for Flexion Therapeutics Inc

Role
Director
Signature
/s/ Mark S. Levine, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
09 Jul 2021
Net transactions value
$0
Form type
4
Filing time
12 Jul 2021, 16:06:15 UTC
Previous filing
09 Jun 2021
Next filing
19 Aug 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FLXN Stock option (right to buy) Award $0 +32,000 $0.000000 32,000 09 Jul 2021 Common Stock 32,000 $7.82 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One-third of the shares subject to the option will vest on July 9, 2022, and the balance of the shares will vest in a series of 24 equal monthly installments thereafter.